Not sure where to start? Get matched →
— Lab results

Sermorelin, lot 1627989.

Sermorelin (3mg/mL) Subcutaneous Cartridge Solution. Compounded by Mills Pharmacy & Apothecary, Birmingham, MI. Tested August 11, 2026 by Eagle Analytical Services Inc., Houston, TX. This lot was tested for sterility, bacterial endotoxins, potency.

— Results

SterilityPass (Day 7)Celsis rapid sterility, direct inoculation
Bacterial endotoxins< 2 EU/mLUSP <85> · Spec limit 1500 EU/mL
Potency90.7% of label — 2.72 mg/mL measured vs 3.00 mg/mL labelUSP <621>
Eagle submission ETX-260729-0250, sample received 7/30/2026. Potency tested 8/10–8/11/2026, sterility 7/31–8/7/2026, endotoxin 7/31–8/3/2026. The report prints no acceptance range for potency. Lab disclaimer on potency: "The potency method(s) used for testing passed system suitability requirements per Eagle SOP 2.500.001. Product-specific method validation is not available for this sample."
Transcribed from the laboratory's certificate of analysis for this lot. Applies to this lot only. This certificate covers the 3 tests above and does not report purity, identity, ph, particulate matter, container closure integrity.

Formulation

Injectable vial5 mL · 2 mg/mL
Sermorelin10 mg
Pepti Pen cartridge3 mL cartridge (300 units) · 3 mg/mL
Sermorelin9 mg
Amounts shown are per unit. Compounded fresh at a US FDA-registered pharmacy.